A coalition of state attorneys general, including those in Pennsylvania and New Jersey, has reached agreements with two ...
The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...
A campaign has been launched to try and reduce the amount of unused medicines that costs the NHS around £300 million a year.
Sen. Baldwin says opponent Hovde “opposes efforts to negotiate with the big pharmaceutical companies to lower the price of ...
About 18.7 million people will save $7.4 billion next year alone thanks to changes to Medicare drug benefits, the ...
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...
Connecticut is part of a multi-state legal settlement with Heritage Pharmaceuticals and Apotex, accused of conspiring to pump ...
Walgreens was accused of wrongly requiring insured customers to pay more than members of its Prescription Savings Club.
I have a real problem with the science behind the DRE,” said attorney Chris Langholz. “It’s junk science and it shouldn’t be ...
As we grow ever-nearer to election day, more public attention is being cast on our nation’s health policy and each ...
Choose wisely, experts say, when you pick your Medicare Part D prescription drug plan for 2025. What's in the formulary matters now more than ever.
Biogen Inc. raised its annual earnings guidance after reporting better-than-expected third-quarter sales and profit, driven ...